Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia.
Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia. Leuk Res. 2014 Sep; 38(9):1126-9.